HCPCS Level II
Medical services
Letter M, 506 codes. CMS HCPCS Level II file dated September 23, 2026.
License: a US government work, in the public domain (Public Domain Mark 1.0).
Run it in Rivvi
Check every code on your export
Upload a claims or charge export. Rivvi flags HCPCS codes that are deleted or replaced, with the replacement and its date.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Blocks
Each block is one hundred codes. Open one instead of paging the whole letter.
Codes
321 to 360 of 506
- M1317Patients who are counseled on connection with a csp and explicitly opt out
- M1318Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
- M1319Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
- M1320Patients who screened positive for at least 1 of the 5 hrsns
- M1321Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
- M1322Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
- M1323Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
- M1324Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
- M1325Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
- M1326Patients with a diagnosis of hypotony
- M1327Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
- M1328Patients with a diagnosis of acute vitreous hemorrhage
- M1329Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
- M1330Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
- M1331Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
- M1332Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
- M1333Acute vitreous hemorrhage
- M1334Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
- M1335Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
- M1336Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
- M1337Acute pvd
- M1338Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
- M1339Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
- M1340Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
- M1341Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period
- M1342Patients who died during the performance period
- M1343Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses
- M1344Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score
- M1345Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score
- M1346Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period
- M1347Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)
- M1348Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)
- M1349Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period
- M1350Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
- M1351Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
- M1352Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment
- M1353Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
- M1354Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
- M1355Suicide risk based on their clinician's evaluation or a clinician-rated tool
- M1356Patients who died during the measurement period